TRIANA Biomedicines

TRIANA Biomedicines is a venture-backed biopharmaceutical company headquartered in Lexington, Massachusetts. The company focuses on discovering and developing novel therapeutics to treat diseases by utilizing a transformative approach based on "molecular glues." These small molecules act by promoting interactions between specific proteins, altering their function or fate, and potentially opening up new avenues for treating previously "undruggable" targets. TRIANA's initial focus is on targeted protein degradation (TPD) for cancer treatment, driven by the desire to develop groundbreaking new medicines.

The company prioritizes a target-first and rational approach to molecular glue discovery, leveraging its proprietary protein:protein pairing engine to identify E3 ligases that can be paired with specific disease targets. TRIANA's drug discovery engine is powered by a combination of high-resolution structural insights, advanced AI and computational tools, and bespoke chemical libraries. The company is expanding its team to accelerate drug discovery and bring significant therapeutic benefits to patients.

TRIANA Biomedicines is a venture-backed biopharmaceutical company dedicated to developing novel therapeutics for treating diseases by harnessing the power of molecular glues. Their technology focuses on identifying small molecules that promote interactions between proteins, altering the fate or function of disease-causing proteins. This innovative approach aims to address previously undruggable targets and develop groundbreaking new cancer medicines, ultimately transforming patient lives with precision medicines.

TRIANA Biomedicines fosters a collaborative and innovative culture where diversity, equity, inclusion, and belonging are valued. They encourage creative thinking, open communication, and a sense of fun among their team members. They are dedicated to their science, patients, and each other, emphasizing the importance of collaboration, mentorship, and professional development.

TRIANA Biomedicines prioritizes Diversity, Equity, Inclusion, and Belonging (DEIB) by fostering a culture that celebrates the unique qualities of its employees, providing opportunities to showcase strengths, and ensuring a positive experience for all while embracing authenticity. They are committed to recruiting diverse talent to drive innovation and growth, create an environment where everyone feels valued and has a voice, and demonstrating through actions that DEIB is an integral part of their company fabric.